QVentures is thrilled to welcome Congenica, one of Britain’s fastest-growing genomics companies, into their portfolio.

QVentures was engaged by Congenica to broaden access to its Series C funding round to Family Offices and sophisticated high net worth individuals. The QVentures investment followed the initial close of the round in November 2020, which raised US$50m/£39m and was led by Legal & General and Tencent, alongside investors such as Parkwalk, Cambridge Innovation Capital, Downing, Xeraya, Puhua Capital, and IDO Investments.